Headquartered in Westchester, IL Fiscal year ends December NYSE: INGR ingredion.com
Ingredion Incorporated (NYSE: INGR) provides ingredient solutions to customers in more than 120 countries. It turns grains, fruits, vegetables and other plant-based materials into value-added ingredients for the food, beverage, animal nutrition, brewing and industrial markets. 2025 annual net sales were approximately $7.2 billion.
The company reports four businesses:
- **Texture & Healthful Solutions:** Specialty starches and clean-label texturizers.
- **Food & Industrial Ingredients–LATAM:** Sweeteners and starches for brewing, beverage and food customers, notably in Mexico, Brazil and the Andean region.
- **Food & Industrial Ingredients–U.S./Canada:** Includes the Argo corn wet-milling facility.
- **All Other:** Stevia and sugar-reduction ingredients from PureCircle, and pea protein from its Protein Fortification business.
Ingredion operates Ingredion Idea Labs innovation centers worldwide and employs more than 11,000 people. In 2026 it sold its majority stake in its Pakistan business. It is pursuing a pending all-cash acquisition of UK-based Tate & Lyle, to be implemented by a scheme of arrangement. Updated
The Argo plant recovery is still not showing up in earnings, and management cut full-year adjusted EPS guidance to $9.25 to $9.70 because of it. Operating income in the Food and Industrial Ingredients US/Canada segment fell 36% to $52 million, driving the quarter's miss with shares already near 52-week lows.
Jim Cramer called packaged food stocks 'so hated' right now, but the data behind the sentiment tells a more complicated story that could catch contrarian buyers off guard.
Pre-Market Stock Futures: Futures are trading higher after the bulls tried to rally stocks on Monday, after the drubbing they took on Friday, and it looks the same way today. While it…
Ingredion Incorporated (NYSE: INGR) provides ingredient solutions to customers in more than 120 countries.
24/7 Wall St.'s 12-month price target for INGR is $105.76, rated Buy. The Wall Street consensus target is $119.50. INGR price prediction →
